These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30884098)

  • 1. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
    L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Stephens D; Punnett AS; Barton M; Allen UD
    Am J Transplant; 2019 Oct; 19(10):2764-2774. PubMed ID: 30884098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients.
    L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Yeung S; Stephens D; Punnett AS; Barton M; Allen UD
    Transplantation; 2019 Nov; 103(11):e369-e374. PubMed ID: 31385930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
    Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU
    Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Gastrointestinal Posttransplant Lymphoproliferative Disorder: Incidence, Clinical Characteristics, and Impact of Major Surgical Interventions Upon Overall Survival.
    Dziegielewski C; Contreras R; Weitzman S; Gerstle JT
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):438-444. PubMed ID: 29794643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.
    Seçkin D; Barete S; Euvrard S; Francès C; Kanitakis J; Geusau A; Del Marmol V; Harwood CA; Proby CM; Ali I; Güleç AT; Durukan E; Lebbé C; Alaibac M; Laffitte E; Cooper S; Bouwes Bavinck JN; Murphy GM; Ferrándiz C; Mørk C; Cetkovská P; Kempf W; Hofbauer GF
    Am J Transplant; 2013 Aug; 13(8):2146-53. PubMed ID: 23718915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the posttransplant lymphoproliferative disorder subtype on survival.
    Koff JL; Li JX; Zhang X; Switchenko JM; Flowers CR; Waller EK
    Cancer; 2018 Jun; 124(11):2327-2336. PubMed ID: 29579330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH; Montone KT; Leahey AM; Hodinka RL; Salhany KE; Belchis DA; Tomaszewski JE
    Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders.
    Dharnidharka VR; Ruzinova MB; Chen CC; Parameswaran P; O'Gorman H; Goss CW; Gu H; Storch GA; Wylie K
    Cancer Med; 2019 Mar; 8(3):1013-1023. PubMed ID: 30697958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post Transplant Lymphoproliferative Disorder risk factors in children: Analysis of a 23-year single-institutional experience.
    Bosse RC; Franke AJ; Paul Skelton W; Woody LE; Bishnoi R; Wang Y; Bhaduri-McIntosh S; Rajderkar D; Shih R; Dang NH; Slayton WB
    Pediatr Transplant; 2020 Aug; 24(5):e13747. PubMed ID: 32497335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: A multicenter analysis.
    West SC; Friedland-Little JM; Schowengerdt KO; Naftel DC; Pruitt Freeze E; Smith KS; Urschel S; Michaels MG; Kirklin JK; Feingold B
    Clin Transplant; 2019 May; 33(5):e13521. PubMed ID: 30861200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
    Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
    J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation.
    Hayes D; Breuer CK; Horwitz EM; Yates AR; Tobias JD; Shinoka T
    Pediatr Cardiol; 2015 Dec; 36(8):1748-53. PubMed ID: 26187515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
    J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
    Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
    Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
    Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.